No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Sanara MedTech's Earnings Call: Growth Amid Challenges
Cantor Fitzgerald Maintains Sanara MedTech(SMTI.US) With Buy Rating, Maintains Target Price $46
H.C. Wainwright Maintains Sanara MedTech(SMTI.US) With Buy Rating, Raises Target Price to $51
Analysts Are Bullish on Top Healthcare Stocks: X4 Pharmaceuticals (XFOR), Sanara MedTech (SMTI)
Sanara MedTech Is Maintained at Buy by HC Wainwright & Co.
Sanara MedTech Analyst Ratings